Source: Eur Respir J 2009; 33: 1062-1067
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Pepin J-L., Viot-Blanc V., Escourrou P., Racineux J-L., Sapene M., Levy P., Dervaux B., Lenne X., Mallart A.. Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study. Eur Respir J 2009; 33: 1062-1067

Member's Comments

No comment yet.

Related content which might interest you: Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms Source: Eur Respir J 2011; 37: 98-105 Year: 2011 Obstructive sleep apnea Source: Respipedia Article Year: 2017 A prospective polysomnographic study on the evolution of complex sleep apnoea Source: Eur Respir J 2011; 38: 329-337 Year: 2011 Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment Source: Eur Respir J 2013; 41: 593-600 Year: 2013 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 The frequency of REM related OSA among patients with mild OSA and the relation between apnea and daytime sleepiness among these patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation Year: 2007 Differences in age of sleep apnea patients with normalized and persistent excessive daytime sleepiness after nCPAP therapy Source: Annual Congress 2004 - CPAP therapy for OSA Year: 2004 Continuous positive airway pressure (CPAP) supported by telemedicine improves sleepiness and quality of life but not blood pressure in high cardiovascular risk obstructive sleep apnea (OSA): A randomized, controlled trial Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing Year: 2013 Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome? Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome Source: Eur Respir J 2001; 17: 838-847 Year: 2001 Daytime sleepiness and polysomnographic variables in sleep apnoea patients Source: Eur Respir J 2007; 30: 110-113 Year: 2007 The impact of ageing and sex on the association between sleepiness and sleep disordered breathing Source: Eur Respir J 2012; 40: 386-393 Year: 2012 Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients Source: Eur Respir J 2004; 23: 891-895 Year: 2004 Effects of solriamfetol on real-world driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021